Unit
Gastroenterology/Hepatology
GASTRO · Dept. I
Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in Switzerland
Overbeck K, Rickenbach M, Cerny A, Moradpur D, Heim M, Malinverni R, Borovicka J, Helbling B, Mullhaupt B, Dufour J, Negro F. Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in Switzerland. Swiss Med Wkly 2010
Feb 3, 2010Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in Switzerland
Feb 3, 2010Swiss Med Wkly 2010
Overbeck K, Rickenbach M, Cerny A, Moradpur D, Heim M, Malinverni R, Borovicka Jan, Helbling B, Mullhaupt B, Dufour J F, Negro F
[44 year old gardener with lower back pain, myalgia and fever]
Bareiss D, Semela D, Heim M, Terracciano L, Hunziker S. [44 year old gardener with lower back pain, myalgia and fever]. Praxis (Bern 1994) 2010; 99:127-32.
Jan 20, 2010[44 year old gardener with lower back pain, myalgia and fever]
Jan 20, 2010Praxis (Bern 1994) 2010; 99:127-32
Bareiss D, Semela David, Heim M, Terracciano L, Hunziker S
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
Rauch A, Hirschel B, Malinverni R, Moradpour D, Mullhaupt B, Witteck A, Beckmann J, Berg T, Bergmann S, Negro F, Telenti A, Bochud P, Swiss Hepatitis C Cohort Study, Heim M, Günthard H, Furrer H, Kutalik Z, Descombes P, Cai T, di Iulio J, Mueller T, Bochud M, Battegay M, Bernasconi E, Borovicka J, Colombo S, Cerny A, Dufour J, Swiss HIV Cohort Study. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010; 138:1338-45, 1345.e1-7.
Jan 11, 2010Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
Jan 11, 2010Gastroenterology 2010; 138:1338-45, 1345.e1-7
Rauch Andri, Hirschel Bernard, Malinverni Raffaele, Moradpour Darius, Mullhaupt Beat, Witteck Andrea, Beckmann Jacques S, Berg Thomas, Bergmann Sven, Negro Francesco, Telenti Amalio, Bochud Pierre-Yves, Swiss Hepatitis C Cohort Study, Heim Markus, Günthard Huldrych F, Furrer Hansjakob, Kutalik Zoltán, Descombes Patrick, Cai Tao, di Iulio Julia, Mueller Tobias, Bochud Murielle, Battegay Manuel, Bernasconi Enos, Borovicka Jan, Colombo Sara, Cerny Andreas, Dufour Jean-François, Swiss HIV Cohort Study
Natürliche Chromoendoskopie
Sawatzki M, Beglinger C, Lugli A, Manz M. Natürliche Chromoendoskopie. Schweiz Med Forum 2010; 10:139.
Jan 1, 2010Natürliche Chromoendoskopie
Jan 1, 2010Schweiz Med Forum 2010; 10:139
Sawatzki Mikael, Beglinger Christoph, Lugli Alessandro, Manz Michael
Dual Transoral Endoscopic Resection of a Symptomatic Giant Brunneroma
Sulz M, Meyenberger C. Dual Transoral Endoscopic Resection of a Symptomatic Giant Brunneroma. Case Rep Gastroenterol 2009; 3:260-264.
Dec 11, 2009Dual Transoral Endoscopic Resection of a Symptomatic Giant Brunneroma
Dec 11, 2009Case Rep Gastroenterol 2009; 3:260-264
Sulz Michael, Meyenberger Christa
Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey
Schoepfer A, Straumann A, Seibold F, Sauter B, de Saussure P, Rogler G, Manz M, Geyer M, Felley C, Binek J, Vavricka S, Michetti P. Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey. Inflammatory bowel diseases 2009
Dec 10, 2009Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey
Dec 10, 2009Inflammatory bowel diseases 2009
Schoepfer Alain M, Straumann Alex, Seibold Frank, Sauter Bernhard, de Saussure Philippe, Rogler Gerhard, Manz Michael, Geyer Martin, Felley Christian, Binek Janek, Vavricka Stephan R, Michetti Pierre
Benefit of baseline cytometry for surveillance of patients with Barrett's esophagus
Vogt N, Schönegg R, Gschossmann J, Borovicka J. Benefit of baseline cytometry for surveillance of patients with Barrett's esophagus. Surgical endoscopy 2009
Dec 8, 2009Benefit of baseline cytometry for surveillance of patients with Barrett's esophagus
Dec 8, 2009Surgical endoscopy 2009
Vogt Nicole, Schönegg René, Gschossmann Jürgen M, Borovicka Jan
Insulin resistance in chronic hepatitis C: mechanisms and clinical relevance
Bernsmeier C, Heim M. Insulin resistance in chronic hepatitis C: mechanisms and clinical relevance. Swiss Med Wkly 2009; 139:678-84.
Nov 28, 2009Insulin resistance in chronic hepatitis C: mechanisms and clinical relevance
Nov 28, 2009Swiss Med Wkly 2009; 139:678-84
Bernsmeier Christine, Heim Markus H
Die Patientensicherheit in der Schweiz
Rose N, Ortner M, Meyenberger C, Blum A. Die Patientensicherheit in der Schweiz - Resultate einer Expertenbefragung. Schweizerische Ärztezeitung 2009; 90:1890-1893.
Nov 25, 2009Die Patientensicherheit in der Schweiz
Nov 25, 2009Schweizerische Ärztezeitung 2009; 90:1890-1893
Rose Norbert, Ortner Maria-Anna J., Meyenberger Christa, Blum André L.
Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C
Bochud P, Negro F, Francioli P, Malinverni R, Cerny A, Moradpour D, Heim M, Borovicka J, Mullhaupt B, Dufour J, Bochud M, Overbeck K, Cai T, Swiss Hepatitis C Cohort Study Group. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. Journal of hepatology 2009; 51:655-66.
Oct 1, 2009Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C
Oct 1, 2009Journal of hepatology 2009; 51:655-66
Bochud Pierre-Yves, Negro Francesco, Francioli Patrick, Malinverni Raffaele, Cerny Andreas, Moradpour Darius, Heim Markus, Borovicka Jan, Mullhaupt Beat, Dufour Jean-François, Bochud Murielle, Overbeck Kathrin, Cai Tao, Swiss Hepatitis C Cohort Study Group
FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C
Heeg M, Spannagl M, Kauke T, Horster S, Schraut W, Raziorrouh B, Gerlach T, Jung M, Zachoval R, Grüner N, Ulsenheimer A, Diepolder H. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C. Gastroenterology 2009; 137:1280-8.e1-6.
Oct 1, 2009FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C
Oct 1, 2009Gastroenterology 2009; 137:1280-8.e1-6
Heeg Malte H J, Spannagl Michael, Kauke Teresa, Horster Sophia, Schraut Winfried, Raziorrouh Bijan, Gerlach Tilman, Jung Maria-Christina, Zachoval Reinhart, Grüner Norbert H, Ulsenheimer Axel, Diepolder Helmut M
Dual Transoral Endoscopic Resection of a Symptomatic Giant Brunneroma
Sulz M, Thurnheer M, Meyenberger C. Dual Transoral Endoscopic Resection of a Symptomatic Giant Brunneroma. Case Rep Gastroenterol 2009; 3:260-264.
Aug 28, 2009Dual Transoral Endoscopic Resection of a Symptomatic Giant Brunneroma
Aug 28, 2009Case Rep Gastroenterol 2009; 3:260-264
Sulz Michael, Thurnheer M, Meyenberger Christa
Severe Legionella pneumophila pneumonia following infliximab therapy in a patient with Crohn's disease
Beigel F, Jürgens M, Filik L, Bader L, Lück C, Göke B, Ochsenkühn T, Brand S, Seiderer J. Severe Legionella pneumophila pneumonia following infliximab therapy in a patient with Crohn's disease. Inflamm Bowel Dis 2009; 15:1240-4.
Aug 1, 2009Severe Legionella pneumophila pneumonia following infliximab therapy in a patient with Crohn's disease
Aug 1, 2009Inflamm Bowel Dis 2009; 15:1240-4
Beigel Florian, Jürgens Matthias, Filik Levent, Bader Lutz, Lück Christian, Göke Burkhard, Ochsenkühn Thomas, Brand Stephan, Seiderer Julia
Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease
Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009; 58:1152-67.
Aug 1, 2009Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease
Aug 1, 2009Gut 2009; 58:1152-67
Brand Stephan
Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients
Berg T, Sarrazin C, Neumann K, Zankel M, Balk H, Buggisch P, Spengler U, Gerlach T, Hinrichsen H, Rasenack J, Möller B, Klinker H, Teuber G, Weich V, Zeuzem S. Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients. Hepatology (Baltimore, Md.) 2009; 50:369-77.
Aug 1, 2009Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients
Aug 1, 2009Hepatology (Baltimore, Md.) 2009; 50:369-77
Berg Thomas, Sarrazin Christoph, Neumann Konrad, Zankel Myrga, Balk Heike, Buggisch Peter, Spengler Ulrich, Gerlach Tilman, Hinrichsen Holger, Rasenack Jens, Möller Bernd, Klinker Hartwig, Teuber Gerlinde, Weich Viola, Zeuzem Stefan
Hepatosplenic T-cell lymphoma in a patient with Crohn's disease
Beigel F, Jürgens M, Tillack C, Subklewe M, Mayr D, Göke B, Brand S, Ochsenkühn T. Hepatosplenic T-cell lymphoma in a patient with Crohn's disease. Nat Rev Gastroenterol Hepatol 2009; 6:433-6.
Jul 1, 2009Hepatosplenic T-cell lymphoma in a patient with Crohn's disease
Jul 1, 2009Nat Rev Gastroenterol Hepatol 2009; 6:433-6
Beigel Florian, Jürgens Matthias, Tillack Cornelia, Subklewe Marion, Mayr Doris, Göke Burkhard, Brand Stephan, Ochsenkühn Thomas
Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany
Dintsios C, Haverkamp A, Wiegand J, Gerlach T, Wedemeyer H, Pape G, Manns M, Krauth C. Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany. European journal of gastroenterology & hepatology 2009
Jun 22, 2009Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany
Jun 22, 2009European journal of gastroenterology & hepatology 2009
Dintsios Charalabos-Markos, Haverkamp Alexander, Wiegand Johannes, Gerlach Tilman, Wedemeyer Heiner, Pape Gerd, Manns Michael, Krauth Christian
Reconstructing signaling pathways from RNAi data using probabilistic Boolean threshold networks
Kaderali L, Dazert E, Zeuge U, Frese M, Bartenschlager R. Reconstructing signaling pathways from RNAi data using probabilistic Boolean threshold networks. Bioinformatics 2009; 25:2229-35.
Jun 19, 2009Reconstructing signaling pathways from RNAi data using probabilistic Boolean threshold networks
Jun 19, 2009Bioinformatics 2009; 25:2229-35
Kaderali Lars, Dazert Eva, Zeuge Ulf, Frese Michael, Bartenschlager Ralf
Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease
Török H, Müller-Myhsok B, Folwaczny C, Göke B, Folwaczny M, Ochsenkühn T, Lohse P, Klein W, Wetzke M, Teshome M, Tonenchi L, Endres I, Glas J, Brand S. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease. Am J Gastroenterol 2009; 104:1723-33.
May 19, 2009Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease
May 19, 2009Am J Gastroenterol 2009; 104:1723-33
Török Helga P, Müller-Myhsok Bertram, Folwaczny Christian, Göke Burkhard, Folwaczny Matthias, Ochsenkühn Thomas, Lohse Peter, Klein Wolfram, Wetzke Martin, Teshome Molla Y, Tonenchi Laurian, Endres Ilona, Glas Jürgen, Brand Stephan
Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease
Glas J, Müller-Myhsok B, Ochsenkühn T, Göke B, Lohse P, Folwaczny M, Koletzko S, Lacher M, Schiemann U, Griga T, Epplen J, Klein W, Pfennig S, Wetzke M, Ripke S, Stallhofer J, Brand S. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease. Am J Gastroenterol 2009; 104:1737-44.
May 19, 2009Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease
May 19, 2009Am J Gastroenterol 2009; 104:1737-44
Glas Jürgen, Müller-Myhsok Bertram, Ochsenkühn Thomas, Göke Burkhard, Lohse Peter, Folwaczny Matthias, Koletzko Sibylle, Lacher Martin, Schiemann Uwe, Griga Thomas, Epplen Jörg T, Klein Wolfram, Pfennig Simone, Wetzke Martin, Ripke Stephan, Stallhofer Johannes, Brand Stephan